No phaseRecruitingAge-related condition
Screening for Abdominal Aortic Aneurysms in the General Practice by Ultraportable Ultrasound (DACEP)
Screening for Abdominal Aortic Aneurysms in the General Practice by Ultraportable Ultrasound: Cluster Randomized Controlled Prospective Multicenter Study in Two Parallel Groups 1:1 in Open-label
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild (Research network)
- Enrolment
- 400 planned
- Conditions
- Abdominal Aortic Aneurysm
- Interventions
- AAA screening by a GP; AAA screening by a radiologist
- Ages
- adults, older adults
- Registry
- NCT05617326
Full record on ClinicalTrials.gov
From the registry
Abdominal aortic aneurysm (AAA) is a localized dilatation of a segment of the aorta artery in its abdominal portion. It affects 1.7% of men aged 65 years and older. In the high-risk population (male smokers aged 65-75 years), its prevalence is estimated to be between 2.8 and 9%. Mortality of ruptured AAAs is high (80% of deaths before hospitalization or perioperatively), whereas mortality of scheduled procedures for unruptured AAAs is less than 5%. AAA screening has been shown to significantly reduce the specific mortality rate in the medium and long term. The French National Authority for Health (HAS) recommends targeted screening for AAA by ultrasound at the radiologist. The target population is male smokers or former smokers aged 65 to 75 years, as well as all persons aged 50 to 75 years with a family history of AAA. Despite recommendations, the rate of access to targeted screening appears low. Ultrasound screening for AAA is a rapid, noninvasive, and reproducible test. It relies primarily on the measurement of the maximum diameter of the abdominal aorta in cross-section. It has…
Primary outcomes
- AAA screening performed at 1 year
History
Primary completion expected
Last registry update
Started
Registered